Drug Type Monoclonal antibody |
Synonyms 4B03-04, FB 1003, FB-1003 |
Target |
Mechanism TrkA activators(Nerve growth factor receptor Trk-A activators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Chronic Pain | Phase 1 | CN | 09 Aug 2022 |